$BTCS
BTCS Inc. Stock $btcs

$btcs Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224033150 Filed on August 19, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$739.2K	$561.2K
YoY Change	133.73%	45.48%
Cost Of Revenue	$543.3K	$168.8K
YoY Change	553.8%	48.62%
Gross Profit	$195.8K	$392.3K
YoY Change	-16.0%	44.17%
Gross Profit Margin	26.5%	69.91%
Selling, General & Admin	$642.5K	$567.4K
YoY Change	125.14%	-8.52%
% of Gross Profit	328.08%	144.63%
Research & Development	$213.3K	$163.8K
YoY Change	43.63%	-9.47%
% of Gross Profit	108.93%	41.74%
Depreciation & Amortization	$1.490K	$1.490K
YoY Change		27.35%
% of Gross Profit	0.76%	0.38%
Operating Expenses	$1.921M	$1.319M
YoY Change	65.83%	-7.94%
Operating Profit	-$1.725M	-$927.0K
YoY Change	86.46%	-20.15%
Interest Expense	-$122.0K	$287.3K
YoY Change	-303.27%	-60.7%
% of Operating Profit
Other Income/Expense, Net	-$7.315M	-$5.801M
YoY Change	-2666.65%	-4170.76%
Pretax Income	-$9.040M	-$6.728M
YoY Change	1312.47%	560.6%
Income Tax
% Of Pretax Income
Net Earnings	-$9.040M	-$6.728M
YoY Change	1312.31%	560.6%
Net Earnings / Revenue	-1222.99%	-1198.85%
Basic Earnings Per Share	-$0.56	-$0.43
Diluted Earnings Per Share	-$0.56	-$0.43
COMMON SHARES
Basic Shares Outstanding	16.17M shares	15.71M shares
Diluted Shares Outstanding	16.16M shares	15.76M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$254.5K	$536.7K
YoY Change	-70.06%	-48.57%
Cash & Equivalents	$254.5K	$536.7K
Short-Term Investments
Other Short-Term Assets	$26.17M	$33.18M
YoY Change	225.13%	296.81%
Inventory
Prepaid Expenses	$96.44K	$180.9K
Receivables
Other Receivables
Total Short-Term Assets	$26.43M	$33.72M
YoY Change	196.81%	258.5%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.015K	$7.500K
YoY Change	-49.88%	-15.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$100.0K	$100.0K
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$106.0K	$107.5K
YoY Change	783.38%	1116.89%
TOTAL ASSETS
Total Short-Term Assets	$26.43M	$33.72M
Total Long-Term Assets	$106.0K	$107.5K
Total Assets	$26.53M	$33.82M
YoY Change	197.6%	259.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$266.8K	$130.9K
YoY Change	196.48%	-30.45%
Accrued Expenses	$1.319M	$639.3K
YoY Change	218.87%	44.6%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.337M	$710.6K
YoY Change	175.7%	-11.0%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.337M	$710.6K
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$1.337M	$710.6K
YoY Change	172.92%	-11.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$142.2M	-$133.1M
YoY Change	-8.0%	-13.49%
Common Stock	$16.56K	$15.90K
YoY Change	15.17%	-99.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$25.20M	$33.11M
YoY Change
Total Liabilities & Shareholders Equity	$26.53M	$33.82M
YoY Change	197.6%	259.3%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$9.040M	-$6.728M
YoY Change	1312.31%	560.6%
Depreciation, Depletion And Amortization	$1.490K	$1.490K
YoY Change		27.35%
Cash From Operating Activities	-$695.2K	-$924.1K
YoY Change	8.63%	0.5%
INVESTING ACTIVITIES
Capital Expenditures	$12.09K	$490.00
YoY Change	20.9%	-99.97%
Acquisitions
YoY Change
Other Investing Activities	$12.05K	$550.4K
YoY Change	-95.7%	-67.09%
Cash From Investing Activities	-$40.00	$549.9K
YoY Change	-100.01%	25594.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	413.0K	240.3K
YoY Change	129.46%	-42.47%
NET CHANGE
Cash From Operating Activities	-695.2K	-924.1K
Cash From Investing Activities	-40.00	549.9K
Cash From Financing Activities	413.0K	240.3K
Net Change In Cash	-282.2K	-133.9K
YoY Change	48.54%	-73.2%
FREE CASH FLOW
Cash From Operating Activities	-$695.2K	-$924.1K
Capital Expenditures	$12.09K	$490.00
Free Cash Flow	-$707.3K	-$924.6K
YoY Change	8.82%	-64.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13773782	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15758157	shares
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7500	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10490	usd
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	107500	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	110490	usd
CY2024Q2	us-gaap	Assets Assets	33823486	usd
CY2023Q4	us-gaap	Assets Assets	27146691	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	130850	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	55058	usd
CY2024Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	508489	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	712092	usd
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	71250	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	213750	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	710589	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	980900	usd
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	385753	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	240305	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	33112897	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001436229
CY2024Q2	BTCS	Receivable For Capital Shares Sold ReceivableForCapitalSharesSold		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
	BTCS	Builder Payments Noncash BuilderPaymentsNoncash		usd
	BTCS	Increase Decrease In Stable Coins IncreaseDecreaseInStableCoins		usd
	BTCS	Increase Decrease In Receivable For Capital Shares Sold IncreaseDecreaseInReceivableForCapitalSharesSold		usd
	BTCS	Series V Preferred Stock Distribution SeriesVPreferredStockDistribution		usd
CY2023Q2	BTCS	Cost Of Builder Revenues CostOfBuilderRevenues		usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases		usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40792
	dei	Entity Registrant Name EntityRegistrantName	BTCS Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1096644
	dei	Entity Address Address Line1 EntityAddressAddressLine1	9466 Georgia Avenue #124
	dei	Entity Address City Or Town EntityAddressCityOrTown	Silver Spring
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20910
	dei	City Area Code CityAreaCode	(202)
	dei	Local Phone Number LocalPhoneNumber	430-6576
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
	dei	Trading Symbol TradingSymbol	BTCS
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16174923	shares
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.001
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	536682	usd
CY2024Q2	BTCS	Stable Coins StableCoins	14797	usd
CY2024Q2	BTCS	Crypto Assets Currencies CryptoAssetsCurrencies	973413	usd
CY2024Q2	BTCS	Staked Crypto Assets Currencies StakedCryptoAssetsCurrencies	32010175	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	180919	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	62461	usd
CY2023Q4	BTCS	Receivable For Capital Shares Sold ReceivableForCapitalSharesSold	291440	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	33715986	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	27036201	usd
CY2024Q2	us-gaap	Investments And Cash InvestmentsAndCash	100000	usd
CY2023Q4	us-gaap	Investments And Cash InvestmentsAndCash	100000	usd
CY2024Q2	us-gaap	Investments Investments	100000	usd
CY2023Q4	us-gaap	Investments Investments	100000	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	975000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	975000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15895027	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15895027	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15320281	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15320281	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	15895	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	15322	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	163681450	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	162263634	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-133148386	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-138677103	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	33112897	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	26165791	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33823486	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27146691	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	561192	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1012578	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	697261	usd
CY2024Q2	us-gaap	Revenues Revenues	561192	usd
CY2023Q2	us-gaap	Revenues Revenues	385753	usd
	us-gaap	Revenues Revenues	1012578	usd
	us-gaap	Revenues Revenues	697261	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	168848	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	113612	usd
	us-gaap	Cost Of Revenue CostOfRevenue	329473	usd
	us-gaap	Cost Of Revenue CostOfRevenue	195626	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	392344	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	272141	usd
	us-gaap	Gross Profit GrossProfit	683105	usd
	us-gaap	Gross Profit GrossProfit	501635	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	538956	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	617569	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1026555	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1227398	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	163777	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	180903	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	310326	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	382528	usd
CY2024Q2	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	875491	usd
CY2023Q2	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	578496	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	1331270	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	1040586	usd
CY2024Q2	us-gaap	Marketing Expense MarketingExpense	28477	usd
CY2023Q2	us-gaap	Marketing Expense MarketingExpense	2723	usd
	us-gaap	Marketing Expense MarketingExpense	86079	usd
	us-gaap	Marketing Expense MarketingExpense	8966	usd
CY2024Q2	BTCS	Realized Gains On Crypto Asset Currency Transactions RealizedGainsOnCryptoAssetCurrencyTransactions	287327	usd
CY2023Q2	BTCS	Realized Gains On Crypto Asset Currency Transactions RealizedGainsOnCryptoAssetCurrencyTransactions	-568031	usd
	BTCS	Realized Gains On Crypto Asset Currency Transactions RealizedGainsOnCryptoAssetCurrencyTransactions	298014	usd
	BTCS	Realized Gains On Crypto Asset Currency Transactions RealizedGainsOnCryptoAssetCurrencyTransactions	-560477	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	1319374	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1947722	usd
	us-gaap	Operating Expenses OperatingExpenses	2456216	usd
	us-gaap	Operating Expenses OperatingExpenses	3219955	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-5943339	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	355033	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	7159328	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	6648240	usd
CY2024Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-142500	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-142500	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-142500	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	142500	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5800839	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	497533	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7301828	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6505740	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-6727869	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1178048	usd
	us-gaap	Net Income Loss NetIncomeLoss	5528717	usd
	us-gaap	Net Income Loss NetIncomeLoss	3787420	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15758157	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13873331	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15724917	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13873331	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19447348	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17263427	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	26165791	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1178084	usd
	us-gaap	Net Income Loss NetIncomeLoss	5528717	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14317540	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	926501	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	789453	usd
	us-gaap	Net Income Loss NetIncomeLoss	3787420	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	19820914	usd
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	4986377	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	39300419	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	240305	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	300042	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-6727869	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	33112897	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	20323408	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	20323408	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	417719	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	257835	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1178048	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	19820914	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	19820914	usd
	us-gaap	Net Income Loss NetIncomeLoss	5528717	usd
	us-gaap	Net Income Loss NetIncomeLoss	3787420	usd
	us-gaap	Depreciation Depreciation	2990	usd
	us-gaap	Depreciation Depreciation	2318	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1178084	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	789453	usd
	BTCS	Blockchain Infrastructure Revenue BlockchainInfrastructureRevenue	1012578	usd
	BTCS	Blockchain Infrastructure Revenue BlockchainInfrastructureRevenue	697261	usd
	BTCS	Builder Payments Noncash BuilderPaymentsNoncash	-158112	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-142500	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	142500	usd
	BTCS	Realized Gain On Crypto Assets Transactions RealizedGainOnCryptoAssetsTransactions	298014	usd
	BTCS	Realized Gain On Crypto Assets Transactions RealizedGainOnCryptoAssetsTransactions	-560477	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	7159328	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	6648240	usd
	BTCS	Increase Decrease In Stable Coins IncreaseDecreaseInStableCoins	6247	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	118458	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	51668	usd
	BTCS	Increase Decrease In Receivable For Capital Shares Sold IncreaseDecreaseInReceivableForCapitalSharesSold	291440	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	75792	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	111417	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-203603	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-41940	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1693099	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2045524	usd
	BTCS	Purchase Of Productive Crypto Assets Currencies For Validating PurchaseOfProductiveCryptoAssetsCurrenciesForValidating	19212	usd
	BTCS	Purchase Of Productive Crypto Assets Currencies For Validating PurchaseOfProductiveCryptoAssetsCurrenciesForValidating	1804213	usd
	BTCS	Sale Of Productive Crypto Assets Currencies SaleOfProductiveCryptoAssetsCurrencies	550361	usd
	BTCS	Sale Of Productive Crypto Assets Currencies SaleOfProductiveCryptoAssetsCurrencies	1719871	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	531149	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-84342	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	240305	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	926501	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	240305	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	926501	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-921645	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1203365	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1458327	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2146783	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	536682	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	943418	usd
	BTCS	Series V Preferred Stock Distribution SeriesVPreferredStockDistribution	2559533	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zti8M4TyENU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_z6fmbM3cWSS2">Reclassifications</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified in order to conform with the current period presentation in the unaudited condensed financial statements and accompanying notes. The reclassifications did not have a material impact on the Company’s unaudited condensed financial statements and related disclosures. The impact on any prior period disclosures was immaterial.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Cash Cash	537000	usd
CY2023Q4	us-gaap	Cash Cash	1458000	usd
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	61000	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	933000	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	287000	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	568000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	298000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	560000	usd
CY2024Q2	us-gaap	Revenues Revenues	561192	usd
CY2023Q2	us-gaap	Revenues Revenues	385753	usd
	us-gaap	Revenues Revenues	1012578	usd
	us-gaap	Revenues Revenues	697261	usd
CY2024Q2	us-gaap	Revenues Revenues	561192	usd
CY2023Q2	us-gaap	Revenues Revenues	385753	usd
	us-gaap	Revenues Revenues	1012578	usd
	us-gaap	Revenues Revenues	697261	usd
CY2024Q2	BTCS	Cost Of Staking Revenues CostOfStakingRevenues	47414	usd
CY2023Q2	BTCS	Cost Of Staking Revenues CostOfStakingRevenues	113612	usd
CY2024Q2	BTCS	Cost Of Builder Revenues CostOfBuilderRevenues	121434	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	168848	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	113612	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zccQtIjZLIej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zkZO7PI6NGJ9">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include the recoverability and useful lives of indefinite life intangible assets, stock-based compensation, and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the indefinite life intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement
	us-gaap	Preferred Stock Conversion Basis PreferredStockConversionBasis	The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board).
CY2024Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	28000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3821373	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3478899	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3478899	shares
CY2022	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	4986000	usd
CY2024Q1	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	65614	usd
CY2024Q1	us-gaap	Revenues Revenues	451387	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	160626	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	290761	usd
CY2024Q2	BTCS	Cost Of Platform Operator Crypto Asset Held For User CostOfPlatformOperatorCryptoAssetHeldForUser	22393848	usd
CY2024Q2	srt	Platform Operator Crypto Asset Held For User PlatformOperatorCryptoAssetHeldForUser	32983588	usd
CY2024Q2	BTCS	Crypto Assets CryptoAssets	32983588	usd
CY2024Q2	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	100000	usd
CY2024Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	33083588	usd
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	71250	usd
CY2023Q4	BTCS	Crypto Assets CryptoAssets	25202929	usd
CY2023Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	100000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	25302929	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	213750	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	100000	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	100000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	213750	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-142500	usd
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	71250	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	97500000	shares
CY2024Q2	us-gaap	Shares Issued SharesIssued	43220	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1200000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.12
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8700	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y4M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	120000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.52
	BTCS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Grants In Period SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGrantsInPeriod	P4Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	17500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	10.30
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1302500	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.96
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4950	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y2M12D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1127500	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.03
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P1Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1606373	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.25
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	300000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.71
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	100000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.63
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	300042	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	228667	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	573471	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	515221	usd
CY2024Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	508489	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	712092	usd
CY2024Q2	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	130850	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	55058	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	639339	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	767150	usd
CY2024Q2	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	505000	usd
CY2023Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	710000	usd
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1	pure
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	109000	usd
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	95000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-133148000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1693000	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-033150-index-headers.html	Edgar Link	pending
0001493152-24-033150-index.html	Edgar Link	pending
0001493152-24-033150.txt	Edgar Link	pending
0001493152-24-033150-xbrl.zip	Edgar Link	pending
btcs-20240630.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
btcs-20240630_def.xml	Edgar Link	unprocessable
btcs-20240630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
btcs-20240630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
btcs-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BTCS
BTCS Inc. Stock $btcs

2024 Q3 Form 10-Q Financial Statement

#000149315224033150 Filed on August 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BTCS BTCS Inc. Stock $btcs

2024 Q3 Form 10-Q Financial Statement

#000149315224033150 Filed on August 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BTCS
BTCS Inc. Stock $btcs